Paul Sauer - 22 Sep 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP Process Dev, Manufacturing
Signature
/s/ Ron Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
22 Sep 2021
Net transactions value
-$133,724
Form type
4
Filing time
24 Sep 2021, 17:04:48 UTC
Next filing
03 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale $133,724 -5,307 -13% $25.20 36,125 22 Sep 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $25.00 to $25.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Includes 1,841 shares acquired under the Employee Stock Purchase Plan on May 17, 2021.